Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs Loss of Pulse Detection

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Acumen Hypotension Prediction Index – EV1000 Clinical Platform
by Edwards Lifesciences
VS
Loss of Pulse Detection
by Fitbit

AI Verdict

Tool A, the Acumen Hypotension Prediction Index, is a clinical decision support system designed for acute care settings, predicting hypotensive events up to 15 minutes in advance to assist clinicians in managing hemodynamic instability. Conversely, Tool B, Fitbit's Loss of Pulse Detection, is a reactive, consumer-facing feature on wearable devices that detects a loss of pulse and automatically alerts emergency services if the user is unresponsive, focusing on personal safety and remote emergency response. While both address cardiovascular health and emergency scenarios, their distinct focus on prediction versus detection and clinical versus remote application makes them serve different primary purposes.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your clinical team requires advanced, real-time predictive analytics to proactively manage hemodynamic stability in high-acuity settings like the OR or ICU. This tool is ideal for preventing intraoperative hypotension by providing early warnings and actionable insights into the underlying causes of instability, allowing for timely intervention and improved patient outcomes.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose Loss of Pulse Detection if…

Choose Fitbit's Loss of Pulse Detection if you or your patients require an automated, personal safety net for out-of-hospital emergencies, particularly for individuals at risk of sudden cardiac events. This feature provides critical peace of mind by automatically detecting a potential loss of pulse and initiating emergency services contact if the user is unresponsive, sharing vital location information for rapid assistance.

View Loss of Pulse Detection →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Loss of Pulse Detection
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) Unknown
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Loss of Pulse Detection

Tool B offers superior usability for the general public as it is integrated into a consumer wearable device and operates automatically with an opt-in feature, requiring minimal user intervention. In contrast, Tool A is part of a sophisticated clinical platform requiring trained medical professionals for operation and interpretation.

Clinical Value

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Tool A provides proactive clinical value by predicting and offering insights into the causes of hypotension, enabling clinicians to intervene before an adverse event occurs. This directly impacts patient management and outcomes in a critical care setting. Tool B, while life-saving, is a reactive measure for an acute event.

Pricing & Value

Loss of Pulse Detection

Tool B offers exceptional value as it is included as a feature with compatible consumer wearable devices, making advanced health monitoring accessible without additional cost. Tool A, conversely, is an enterprise solution with a 'contact-for-pricing' model, indicating a substantial investment for healthcare institutions.

Enterprise Readiness

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Tool A is explicitly designed as an enterprise-grade solution, integrating with established clinical monitoring platforms within hospital systems and critical care units. Its development by a major medical device company like Edwards Lifesciences and its deployment model confirm its readiness for complex healthcare environments. Tool B is a consumer-facing feature, not built for enterprise-level clinical workflow integration.

Innovation

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Tool A demonstrates higher innovation through its advanced machine learning algorithm that not only predicts hypotension but also provides actionable insights into its potential causes, enabling proactive clinical intervention. While Tool B offers a valuable automated emergency response, its core pulse detection technology is more established in wearables.

Support & Docs

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Tool A, as a specialized medical device from Edwards Lifesciences, is backed by extensive professional support, clinical education, and detailed technical documentation tailored for healthcare professionals. Tool B, being a feature on a consumer device, relies on general consumer support channels and user manuals.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Loss of Pulse Detection
Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform Loss of Pulse Detection
Company Edwards Lifesciences Fitbit
Primary Function Uses machine learning to predict hypotensive events up to 15 minutes in advance, providing clinicians with insights into hemodynamic instability and potential causes to help reduce intraoperative hypotension. Uses PPG and accelerometry to detect a potential loss of pulse and can automatically alert emergency services if the user is unresponsive.
Key Predictive/Detection Capability Predicts hypotension up to 15 minutes in advance Automatic loss of pulse detection
Sensor Technology Used Non-invasive (Acumen IQ cuff) and minimally-invasive (Acumen IQ sensor) options Utilizes PPG and accelerometry sensors
Target Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology, Critical Care, Emergency Medicine

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and Loss of Pulse Detection.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI is integrated with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform, providing real-time, continuous hemodynamic monitoring for in-hospital surgical and critical care patients. Fitbit's Loss of Pulse Detection is a feature on compatible wearable devices, designed for remote, out-of-hospital use, automatically alerting emergency services if a user is unresponsive after a potential loss of pulse.
Acumen HPI provides a likelihood score (0-100) for hypotension up to 15 minutes in advance, along with a 'Relationship View' screen offering insights into preload, afterload, and contractility to help identify the root cause of hemodynamic instability. Fitbit's Loss of Pulse Detection primarily detects a potential loss of pulse and triggers emergency services, sharing location and an automated message, but it does not offer diagnostic insights or follow-up care.
Acumen HPI is intended for surgical and non-surgical patients receiving advanced hemodynamic monitoring in settings like anesthesiology, critical care, and emergency medicine, particularly to reduce intraoperative hypotension. Fitbit's Loss of Pulse Detection is for individuals wearing compatible smartwatches, primarily for over-the-counter use to detect potential loss of pulse events and alert emergency services for unresponsive users outside of a clinical setting.
Acumen HPI uses a machine learning algorithm to predict hypotension up to 15 minutes in advance, demonstrating high accuracy with a specificity of 89% and sensitivity of 90% at 10 minutes before an event. Fitbit's Loss of Pulse Detection utilizes PPG and accelerometry to detect a potential loss of pulse, with a clinical study showing a sensitivity of 64.5% after adjusting for simulated collapse and a day-level specificity of 99.965%.
For Acumen HPI, clinical staff would need to learn to interpret the HPI parameter (0-100 score), Smart Alerts, Smart Trend screen, and Relationship View screen for hemodynamic insights. Fitbit's Loss of Pulse Detection is a user-facing feature on a wearable device, so the learning curve for clinical staff would primarily involve understanding the alert mechanism and how patients can share data, rather than direct operational use.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform or Loss of Pulse Detection

Backers

Who funded each tool's parent company.

Loss of Pulse Detection

AI Tool Finder
AI-powered search. Results may not be comprehensive.